PT90138A - Processo de preparacao de peptidos de factor de crescimento do nervo - Google Patents

Processo de preparacao de peptidos de factor de crescimento do nervo

Info

Publication number
PT90138A
PT90138A PT9013889A PT9013889A PT90138A PT 90138 A PT90138 A PT 90138A PT 9013889 A PT9013889 A PT 9013889A PT 9013889 A PT9013889 A PT 9013889A PT 90138 A PT90138 A PT 90138A
Authority
PT
Portugal
Prior art keywords
growth factor
preparation process
nerve growth
factor peptides
peptides
Prior art date
Application number
PT9013889A
Other languages
English (en)
Inventor
Frank M Longo
William C Mobley
James Charles Kauer
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of PT90138A publication Critical patent/PT90138A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1019Tetrapeptides with the first amino acid being basic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/48Nerve growth factor [NGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PT9013889A 1988-03-28 1989-03-28 Processo de preparacao de peptidos de factor de crescimento do nervo PT90138A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17397588A 1988-03-28 1988-03-28
US29969889A 1989-01-10 1989-01-10

Publications (1)

Publication Number Publication Date
PT90138A true PT90138A (pt) 1989-11-10

Family

ID=26869739

Family Applications (1)

Application Number Title Priority Date Filing Date
PT9013889A PT90138A (pt) 1988-03-28 1989-03-28 Processo de preparacao de peptidos de factor de crescimento do nervo

Country Status (4)

Country Link
EP (1) EP0335637A3 (pt)
AU (1) AU3418389A (pt)
PT (1) PT90138A (pt)
WO (1) WO1989009225A1 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4004573A1 (de) * 1989-02-17 1990-08-23 Tanabe Seiyaku Co Neues versuchstier und seine herstellung
SE465573B (sv) * 1989-03-14 1991-09-30 Lope Medicine Ab Nervtillvaextfaktorpeptider, motsvarande antikroppar och foerfarande foer bestaemning av nativ nervtillvaextfaktor
JP2745351B2 (ja) * 1991-02-14 1998-04-28 富士写真フイルム株式会社 ペプチド誘導体及びその用途
WO1993019088A1 (en) * 1992-03-17 1993-09-30 Board Of Regents, The University Of Texas System Neurotrophic peptides
US5281607B1 (en) * 1992-10-08 1998-05-19 Univ New York Method of using alpha 2-antagonists for the treatment of neurodegenerative diseases
GB9402331D0 (en) * 1994-02-07 1994-03-30 Univ Mcgill Nerve growth factor structural analogs and their uses
US6291247B1 (en) 1994-05-11 2001-09-18 Queen's University At Kingston Methods of screening for factors that disrupt neurotrophin conformation and reduce neurotrophin biological activity
GB9616105D0 (en) * 1996-07-31 1996-09-11 Univ Kingston TrkA binding site of NGF
IT1306704B1 (it) * 1999-05-26 2001-10-02 Sirs Societa Italiana Per La R Anticorpi monoclonali e suoi derivati sintetici o biotecnologici ingrado di agire come molecole antagoniste per il ngf.
UA80447C2 (en) 2002-10-08 2007-09-25 Methods for treating pain by administering nerve growth factor antagonist and opioid analgesic
BR0315164A (pt) 2002-10-08 2005-08-23 Rinat Neuroscience Corp Métodos para tratar dor pós-cirúrgica administrando um antagonista de fator de crescimento nervoso e composições contendo o mesmo
SI1575517T1 (sl) 2002-12-24 2012-06-29 Rinat Neuroscience Corp Protitelesa proti ĺ˝iväśnemu rastnemu dejavniku in metode njihove uporabe
US9498530B2 (en) 2002-12-24 2016-11-22 Rinat Neuroscience Corp. Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
US7569364B2 (en) 2002-12-24 2009-08-04 Pfizer Inc. Anti-NGF antibodies and methods using same
ATE491444T1 (de) 2003-02-19 2011-01-15 Rinat Neuroscience Corp Verfahren zur behandlung von schmerzen durch verabreichung eines nervenwachstumsfaktor- antagonisten und eines nsaid und diese enthaltende zusammensetzung
US7223745B2 (en) 2003-08-14 2007-05-29 Cephalon, Inc. Proteasome inhibitors and methods of using the same
US7576206B2 (en) 2003-08-14 2009-08-18 Cephalon, Inc. Proteasome inhibitors and methods of using the same
ES2338344T3 (es) 2004-04-07 2010-05-06 Rinat Neuroscience Corporation Procedimiento de tratamiento del dolor de cancer de hueso mediante la administracion de una antagonista del factor de crecimiento neuronal.
US20080226639A1 (en) * 2004-06-10 2008-09-18 Enkan Pharmaceuticals A/S Heparin Binding Peptide
US7468383B2 (en) 2005-02-11 2008-12-23 Cephalon, Inc. Proteasome inhibitors and methods of using the same
RU2410392C2 (ru) * 2009-02-16 2011-01-27 Учреждение Российской академии медицинских наук Научно-исследовательский институт фармакологии имени В.В. Закусова РАМН Дипептидные миметики нейротрофинов ngf и bdnf
WO2011087822A1 (en) 2009-12-22 2011-07-21 Cephalon, Inc. Proteasome inhibitors and processes for their preparation, purification and use
ES2665954T3 (es) 2010-08-19 2018-04-30 Zoetis Belgium S.A. Anticuerpos anti-NGF y su uso
WO2013184871A1 (en) 2012-06-06 2013-12-12 Zoetis Llc Caninized anti-ngf antibodies and methods thereof
BR112020017701A2 (pt) 2018-03-12 2020-12-29 Zoetis Services Llc Anticorpos anti-ngf e métodos dos mesmos
WO2023212596A1 (en) 2022-04-27 2023-11-02 Regeneron Pharmaceuticals, Inc. Treatment of arthropathy based upon stratification of osteoarthritis polygenic risk score
US20240310383A1 (en) 2023-03-17 2024-09-19 Regeneron Pharmaceuticals, Inc. Proteomic Risk Score For Osteoarthritis (OA)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230691A (en) * 1978-05-23 1980-10-28 The Massachusetts General Hospital Nerve growth factor antibody and process
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
WO1986004334A1 (en) * 1985-01-18 1986-07-31 MERCK Patent Gesellschaft mit beschränkter Haftung Immunoregulatory peptides

Also Published As

Publication number Publication date
EP0335637A3 (en) 1991-03-13
EP0335637A2 (en) 1989-10-04
AU3418389A (en) 1989-10-16
WO1989009225A1 (en) 1989-10-05

Similar Documents

Publication Publication Date Title
PT90138A (pt) Processo de preparacao de peptidos de factor de crescimento do nervo
PT90637A (pt) Processo de preparacao de polianidridos
PT93830A (pt) Processo de preparacao de perfluropolieteres peroxidicos
FI107430B (fi) Synteettisiä kasvigeenejä ja valmistusmenetelmä
FI102969B1 (fi) Lämpö- ja pH-stabiileja subtilisiinianalogeja ja menetelmä niiden valmistamiseksi
BR8907085A (pt) Processo de preparacao de composicoes de betume-polimero
PT83643B (pt) Processo de preparacao de derivados de quinoleina
BR8905184A (pt) Processo de preparacao de(co)poliamidas amorfas
PT89946A (pt) Processo de preparacao de sulfatos ciclicos
BR8707471A (pt) Vacina e processo de preparacao
PT91098A (pt) Processo de preparacao de derivados de (aza)naftalenossultame
BR8902861A (pt) Processo de preparacao de copoliamidas amorfas e transparentes e sua aplicacao
BR8906686A (pt) Processo de preparacao de formulacao pesticida estavel
IT8947842A0 (it) Procedimento per la produzione di r(+) amminocarnitina e s(-) amminocarnitina
PT86069A (pt) Processo de preparacao de ureia
PT92171A (pt) Processo de preparacao de n-fosfonometil-glicina
PT84624B (pt) Processo de preparacao de imidazois substituidos
PT89491A (pt) Processo de preparacao de polimeros de organoborossilazanos
PT84553B (pt) Processo de preparacao de derivados de indenopirimidina
ZA878328B (en) Process of fertilisation of vineyards
PT94032A (pt) Processo de preparacao de betao betuminoso contendo pedacos de arame
BR9305837A (pt) Processo de preparação de 3-carbonilandrostadieno 17-carboxamidas
BR1100721A (pt) Processo de produção do fator de crescimento de nervo humano
PT81505B (pt) Processo de preparacao de esteres do dietileno-glicol
AU2846689A (en) Methods for preparing proteins of altered structure

Legal Events

Date Code Title Description
FC3A Refusal

Effective date: 19940531